Summary
For Year 2026-27, Dr Lal Pathlabs. reports the following shareholding: Total Promoters at 53.21%, Mutual Fund at 18.62%, Insurance at 2.33%, Foreign Institutional Investors at 17.18%, Domestic Institutional Investors at 0.3%, and Retail at 8.35%. This breakdown provides a quick snapshot of ownership distribution for Dr Lal Pathlabs. in 2026-27.
Dr Lal Pathlabs. FAQs
As of 04-2026, the promoter shareholding in Dr Lal Pathlabs. stands at 53.21% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Dr Lal Pathlabs. is 17.18% and 0.3% respectively.
The retail shareholding of the Dr Lal Pathlabs. is 8.35%.
Changes in shareholding patterns of Dr Lal Pathlabs. can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Dr Lal Pathlabs. are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Dr Lal Pathlabs. Associated Pages
